National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Insulin Lispro
Synonyms

INSULIN LISPRO

Insulin Lispro

Humalog

Definitions

A recombinant therapeutic agent which is chemically identical to or similar to endogenous human insulin. In lispro insulin, the amino acid proline at B-28 and the amino acid lysine at B-29 are reversed, resulting in the rapid dissolution of this insulin to a monomer that is absorbed rapidly after subcutaneous administration. Lispro insulin is equipotent to human insulin on a molar basis but its effects are faster and of shorter duration. Endogenous insulin, a pancreatic hormone composed of two polypeptide chains, is important in the normal metabolism of carbohydrates, proteins and fats, promoting glucose utilization and protein synthesis; it has anabolic effects on many types of tissues. (NCI04)

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29123

CAS_Registry

133107-64-9

Chemical_Formula

C257H383N65O77S6

code

C29123

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

A recombinant therapeutic agent which is chemically identical to or similar to endogenous human insulin. In lispro insulin, the amino acid proline at B-28 and the amino acid lysine at B-29 are reversed, resulting in the rapid dissolution of this insulin to a monomer that is absorbed rapidly after subcutaneous administration. Lispro insulin is equipotent to human insulin on a molar basis but its effects are faster and of shorter duration. Endogenous insulin, a pancreatic hormone composed of two polypeptide chains, is important in the normal metabolism of carbohydrates, proteins and fats, promoting glucose utilization and protein synthesis; it has anabolic effects on many types of tissues. (NCI04)

FDA_UNII_Code

GFX7QIS1II

FULL_SYN

INSULIN LISPRO

Insulin Lispro

Humalog

label

Insulin Lispro

Legacy Concept Name

Lispo_Insulin

Preferred_Name

Insulin Lispro

prefixIRI

Thesaurus:C29123

Semantic_Type

Amino Acid, Peptide, or Protein

Pharmacologic Substance

UMLS_CUI

C0293359

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C581

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_232799 CHEBI LOOM
http://purl.obolibrary.org/obo/DRON_00017625 DRON LOOM
http://purl.bioontology.org/ontology/NDDF/006061 NDDF LOOM
http://purl.obolibrary.org/obo/NCIT_C29123 BERO LOOM
http://purl.obolibrary.org/obo/DRON_00017625 PDRO LOOM
http://purl.obolibrary.org/obo/DRON_00017625 DDSS LOOM
https://go.drugbank.com/drugs/DB00046 MDM LOOM
http://purl.obolibrary.org/obo/MESH_D061268 BERO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D06.472.699.587.200.400.500 RH-MESH LOOM
http://www.semanticweb.org/khaled/ontologies/2024/7/CDMOnto#Insulin-Lispro CDMONTO LOOM
http://purl.bioontology.org/ontology/ATC/A10AD04 ATC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D061268 RH-MESH LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000752177 PDQ LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/412210000 SNOMEDCT LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D12.644.548.586.200.400.500 RH-MESH LOOM
http://purl.bioontology.org/ontology/ATC/A10AB04 ATC LOOM
http://purl.bioontology.org/ontology/RXNORM/86009 RXNORM LOOM
http://purl.jp/bio/4/id/200906051482068464 IOBC LOOM
http://www.drugbank.ca/drugs/DB00046 FTC LOOM
http://purl.bioontology.org/ontology/RCD/f13.. RCD LOOM
http://www.co-ode.org/ontologies/galen#InsulinLispro GALEN LOOM
http://purl.bioontology.org/ontology/ATC/A10AC04 ATC LOOM
http://purl.bioontology.org/ontology/MESH/D061268 MESH LOOM
http://purl.obolibrary.org/obo/OMIT_0027940 OMIT LOOM
http://purl.obolibrary.org/obo/dinto_DB00046 DINTO LOOM
http://www.phoc.org.cn/pmo/class/PMO_00019147 PMAPP-PMO LOOM